Fed. Circ. Upholds AstraZeneca's Seroquel Patent Win

Law360, New York (September 25, 2009, 3:15 PM EDT) -- The U.S. Court of Appeals for the Federal Circuit has upheld a lower court's ruling that AstraZeneca Pharmaceuticals LP did not engage in inequitable conduct when seeking a patent for its antipsychotic drug Seroquel, rejecting a challenge by generics makers Sandoz Inc. and Teva Pharmaceutical Industries Ltd.

In a ruling Friday, the appeals court upheld the grant of summary judgment to AstraZeneca by the of the U.S. District Court for the District of New Jersey. The lower court's ruling ended the case because Teva and Sandoz...
To view the full article, register now.